Insight
ESMO Open Shared 2025 Study Linking KRAS Variants to Therapeutic Outcomes in Biliary Tract Cancers
Photo: Depositphotos

ESMO Open Shared 2025 Study Linking KRAS Variants to Therapeutic Outcomes in Biliary Tract Cancers

ESMO Open shared a post on X:

“Association of KRAS variants with survival and therapeutic outcomes in biliary tract cancers in ESMO Open.
KRAS mutations occur in 23.4% of BTC, more frequent in intrahepatic and extrahepatic colangiocarcinoma, and associated with worse survival.”

Title: Association of KRAS variants with survival and therapeutic outcomes in biliary tract cancers

Journal: ESMO Open

Authors: K. Iida, Y. Matsui, Y. Urabe, T. Muramatsu, J. Matsuzaki, Y. Saito

Read the full article.

KRAS Variants

More posts featuring ESMO Open on OncoDaily.

Biliary tract cancer BTC cancer colangiocarcinoma ESMO Open J. Matsuzaki K. Iida KRAS OncoDaily Oncology T. Muramatsu Y. Matsui Y. Saito Y. Urabe